Searched for: in-biosketch:true
person:segevd01
Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study
Killian, A Cozette; Reed, Rhiannon D; McLeod, M Chandler; MacLennan, Paul A; Kumar, Vineeta; Pittman, Sydney E; Maynor, Andrew G; Stanford, Luke A; Baker, Gavin A; Schinstock, Carrie A; Silkensen, John R; Roll, Garrett R; Segev, Dorry L; Orandi, Babak J; Lewis, Cora E; Locke, Jayme E
BACKGROUND:Approval of living kidney donors (LKD) with end-stage kidney disease (ESKD) risk factors, such as obesity, has increased. While lifetime ESKD development data are lacking, the study of intermediate outcomes such as diabetes is critical for LKD safety. Donation-attributable diabetes risk among persons with obesity remains unknown. The purpose of this study was to evaluate 10-year diabetes-free survival among LKDs and non-donors with obesity. METHODS:This longitudinal cohort study identified adult, LKDs (1976-2020) from 42 US transplant centers and non-donors from the Coronary Artery Risk Development in Young Adults (1985-1986) and the Atherosclerosis Risk in Communities (1987-1989) studies with body mass index ≥30 kg/m2. LKDs were matched to non-donors on baseline characteristics (age, sex, race, body mass index, systolic and diastolic blood pressure) plus diabetes-specific risk factors (family history of diabetes, impaired fasting glucose, smoking history). Accelerated failure time models were utilized to evaluate 10-year diabetes-free survival. FINDINGS:Among 3464 participants, 1119 (32%) were LKDs and 2345 (68%) were non-donors. After matching on baseline characteristics plus diabetes-specific risk factors, 4% (7/165) LKDs and 9% (15/165) non-donors developed diabetes (median follow-up time 8.5 (IQR: 5.6-10.0) and 9.1 (IQR: 5.9-10.0) years, respectively). While not significant, LKDs were estimated to live diabetes-free 2 times longer than non-donors (estimate 1.91; 95% CI: 0.79-4.64, p = 0.15). CONCLUSIONS:LKDs with obesity trended toward living longer diabetes-free than non-donors with obesity, suggesting within the decade following donation there was no increased diabetes risk among LKDs. Further work is needed to evaluate donation-attributable diabetes risk long-term.
PMCID:9674148
PMID: 36399462
ISSN: 1932-6203
CID: 5371742
Short Report: Race and Ethnicity Misclassification in Kidney Transplantation Research
Kernodle, Amber B; Thompson, Valerie; Chen, Xiaomeng; Norman, Silas P; Segev, Dorry L; Purnell, Tanjala S; McAdams-DeMarco, Mara
Recently, the misuse of race as a biological variable, rather than a social construct, in biomedical research has received national attention for its contributions to medical bias. In national transplant registry data, bias may arise from measurement imprecision because of the collection of provider-perceived race rather than patients' own self-report.
PMCID:9529064
PMID: 36204185
ISSN: 2373-8731
CID: 5361792
Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation
Bisen, Shivani S; Getsin, Samantha N; Chiang, Po-Yu; Herrick-Reynolds, Kayleigh; Zeiser, Laura B; Yu, Sile; Desai, Niraj M; Al Ammary, Fawaz; Jackson, Kyle R; Segev, Dorry L; Massie, Allan B
ABO type B and O kidney transplant candidates have increased difficulty identifying a compatible donor for living donor kidney transplantation (LDKT) and are harder to match in kidney paired donation registries. A2-incompatible (A2i) LDKT increases access to LDKT for these patients. To better inform living donor selection, we evaluated the association between A2i LDKT and patient and graft survival.
PMCID:9584180
PMID: 36284928
ISSN: 2373-8731
CID: 5359432
The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
Benner, Sarah E; Eby, Yolanda; Zhu, Xianming; Fernandez, Reinaldo E; Patel, Eshan U; Ruff, Jessica E; Habtehyimer, Feben; Schmidt, Haley A; Kirby, Charles S; Hussain, Sarah; Ostrander, Darin; Desai, Niraj M; Florman, Sander; Rana, Meenakshi M; Friedman-Moraco, Rachel; Pereira, Marcus R; Mehta, Shikha; Stock, Peter; Gilbert, Alexander; Morris, Michele I; Stosor, Valentina; Mehta, Sapna A; Small, Catherine B; Ranganna, Karthik; Santos, Carlos Aq; Aslam, Saima; Husson, Jennifer; Malinis, Maricar; Elias, Nahel; Blumberg, Emily A; Doby, Brianna L; Massie, Allan B; Smith, Melissa L; Odim, Jonah; Quinn, Thomas C; Laird, Gregory M; Siliciano, Robert F; Segev, Dorry L; Redd, Andrew D; Durand, Christine M; Tobian, Aaron Ar
The HIV latent viral reservoir (LVR) remains a major challenge in the effort to find a cure for HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow transplantation to reduce the LVR. This study evaluated the LVR and T cell receptor repertoire in HIV-infected kidney transplant recipients using intact proviral DNA assay and T cell receptor sequencing in patients receiving lymphocyte-depleting or lymphocyte-nondepleting immunosuppression induction therapy. CD4+ T cells and intact and defective provirus frequencies decreased following lymphocyte-depleting induction therapy but rebounded to near baseline levels within 1 year after induction. In contrast, these biomarkers were relatively stable over time in the lymphocyte-nondepleting group. The lymphocyte-depleting group had early TCRβ repertoire turnover and newly detected and expanded clones compared with the lymphocyte-nondepleting group. No differences were observed in TCRβ clonality and repertoire richness between groups. These findings suggest that, even with significant decreases in the overall size of the circulating LVR, the reservoir can be reconstituted in a relatively short period of time. These results, while from a relatively unique population, suggest that curative strategies aimed at depleting the HIV LVR will need to achieve specific and durable levels of HIV-infected T cell depletion.
PMID: 36345940
ISSN: 2379-3708
CID: 5357162
Maximizing the use of potential donors through increased rates of family approach for authorization
Levan, Macey L; Massie, Allan B; Trahan, Chad; Hewlett, Jonathan; Strout, Tyler; Klitenic, Samantha B; Vanterpool, Karen B; Segev, Dorry L; Adams, Bradley L; Niles, Patricia
In the United States, a small proportion of potential deceased organ donor referrals lead to donation and recovery. Understanding variation in the processes involved between organ procurement organizations (OPOs) may help increase deceased donation and reduce the organ shortage. We studied 103 923 referrals from 10 OPOs from 2018 to 2019, of which 14.4% led to approach for authorization, 8.2% led to authorization, 5.1% led to organ recovery, and 4.8% led to transplantation. First-person authorization (FPA) was associated with threefold higher odds of donation (OR = 2.83 3.02 3.22 , p < .001). Female referrals had 11% lower odds of approach; when approached, Black and Hispanic referrals had 46% and 35% lower odds of authorization, respectively (all p < .001). There was substantial OPO-level variation in rates of approach, authorization, and organ recovery, which persisted after adjusting for age, sex, race, and FPA status. An OPO's relative rate of approach correlated strongly with its relative rate of donation among all referrals (Ï = 0.43). Correlation between an individual OPO's authorization rate among approached families, and overall rate of donation, was negative, suggesting that high authorization rates may be the result of selective approach practices. Therefore, approaching a higher proportion of families for authorization may lead to higher donation rates.
PMID: 36062407
ISSN: 1600-6143
CID: 5336932
Increased Logistical Burden in Circle-based Kidney Allocation
Wood, Nicholas L; VanDerwerken, Douglas N; Segev, Dorry L; Gentry, Sommer E
PMID: 36173652
ISSN: 1534-6080
CID: 5334452
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients [Letter]
Alejo, Jennifer L; Ruck, Jessica M; Chiang, Teresa P Y; Abedon, Aura T; Kim, Jake D; Avery, Robin K; Tobian, Aaron A R; Warren, Daniel S; Levan, Macey L; Massie, Allan B; Garonzik-Wang, Jacqueline M; Segev, Dorry L; Werbel, William A
PMID: 36073912
ISSN: 1399-0012
CID: 5332532
Delirium, changes in cognitive function, and risk of diagnosed dementia after kidney transplantation
Chu, Nadia M; Bae, Sunjae; Chen, Xiaomeng; Ruck, Jessica; Gross, Alden L; Albert, Marilyn; Neufeld, Karin J; Segev, Dorry L; McAdams-DeMarco, Mara A
Kidney transplant (KT) recipients with delirium, a preventable surgical complication, are likely to reap cognitive benefits from restored kidney function, but may be more vulnerable to longer-term neurotoxic stressors post-KT (i.e., aging, immunosuppression). In this prospective cohort study, we measured delirium (chart-based), global cognitive function (3MS), and executive function (Trail Making Test Part B minus Part A) in 894 recipients (2009-2021) at KT, 1/3/6-months, 1-year, and annually post-KT. Dementia was ascertained using linked Medicare claims. We described repeated measures of cognitive performance (mixed effects model) and quantified dementia risk (Fine & Gray competing risk) by post-KT delirium. Of 894 recipients, 43(4.8%) had post-KT delirium. Delirium was not associated with global cognitive function at KT (difference = -3.2 points, 95%CI: -6.7, 0.4) or trajectories post-KT (0.03 points/month, 95%CI: -0.27, 0.33). Delirium was associated with worse executive function at KT (55.1 s, 95%CI: 25.6, 84.5), greater improvements in executive function <2 years post-KT (-2.73 s/month, 95%CI: -4.46,-0.99), and greater decline in executive function >2 years post-KT (1.72 s/month, 95%CI: 0.22, 3.21). Post-KT delirium was associated with over 7-fold greater risk of dementia post-KT (adjusted subdistribution hazard ratio = 7.84, 95%CI: 1.22, 50.40). Transplant centers should be aware of cognitive risks associated with post-KT delirium and implement available preventative interventions to reduce delirium risk.
PMID: 35980673
ISSN: 1600-6143
CID: 5331452
Sex-Adjusted Model for End-stage Liver Disease Scores for Liver Transplant Allocation
Wood, Nicholas L; Segev, Dorry L; Gentry, Sommer E
PMID: 36069929
ISSN: 2168-6262
CID: 5332442
Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave [Letter]
Alejo, Jennifer L; Chiang, Teresa Py; Mitchell, Jonathan; Abedon, Aura T; Jefferis, Alexa A; Werbel, William; Massie, Allan B; Makary, Martin A; Segev, Dorry L
PMID: 35946381
ISSN: 1365-2796
CID: 5286902